<DOC>
	<DOCNO>NCT01905735</DOCNO>
	<brief_summary>purpose study assess safety efficacy commonly use Homeopathic medicine Rhustoxicodendron 30 potency treatment Rheumatoid arthritis .</brief_summary>
	<brief_title>A Safety Efficacy Homeopathic Medicine Rhus Toxicodendron 30 Treatment Rheumatoid Arthritis</brief_title>
	<detailed_description>multicenter phase 2 , double blind study patient active Rheumatoid arthritis , 2 group study A B , group A receive Rhustoxicodendron 30 potency first dose administer orally ( 1/2 ml ) completion case taking , repeat every 7th day 5 month hand group B receive placebo orally ( 1/2 ml ) interval period .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>provide write consent participate study patient willing turn 7th day follow patient willing compliance study 25 60 year . patient willing compliance study . ESR 28 mm . Participating subject clinical research study . Children age 25years . Female subject pregnant planning pregnancy within 6 month . History seizure Breast feed woman 's . Patient treatment life threaten illness like cancer aid etc . Patient congenital abnormality patient undergone operative procedure consequence RA .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>RA</keyword>
</DOC>